Qingyi Wei, PhD

Professor in Population Health Sciences
Professor in Medicine
Member of the Duke Cancer Institute
Campus mail 103858, GSRB1 Room 3015C, Durham, NC 27710
Phone (919) 660-0562
Email address qingyi.wei@duke.edu

Qingyi Wei, MD, PhD, Professor in the Department of Medicine, is Associate Director for Cancer Control and Population Sciences, Co-leader of CCPS and Co-leader of Epidemiology and Population Genomics (Focus Area 1). He is a professor of Medicine and an internationally recognized epidemiologist focused on the molecular and genetic epidemiology of head and neck cancers, lung cancer, and melanoma. His research focuses on biomarkers and genetic determinants for the DNA repair deficient phenotype and variations in cell death. He is Editor-in-Chief of the open access journal "Cancer Medicine" and Associate Editor-in-Chief of the International Journal of Molecular Epidemiology and Genetics.

Area of Expertise: Epidemiology

Education and Training

  • Ph.D., Johns Hopkins Bloomberg School of Public Health, 1993
  • B.M., Nanjing Medical University (China), 1983

Publications

Qian, Danwen, Hongliang Liu, Xiaomeng Wang, Jie Ge, Sheng Luo, Edward F. Patz, Patricia G. Moorman, et al. “Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival..” Int J Cancer 144, no. 8 (April 15, 2019): 1867–76. https://doi.org/10.1002/ijc.31896.

PMID
30259978
Full Text

Dai, Wen, Le Lv, Jibao Lu, Hao Hou, Qingwei Yan, Fakhr E. Alam, Yifan Li, et al. “A Paper-Like Inorganic Thermal Interface Material Composed of Hierarchically Structured Graphene/Silicon Carbide Nanorods..” Acs Nano 13, no. 2 (February 26, 2019): 1547–54. https://doi.org/10.1021/acsnano.8b07337.

PMID
30726676
Full Text

Dai, Wei, Hongliang Liu, Xinyuan Xu, Jie Ge, Sheng Luo, Dakai Zhu, Christopher I. Amos, et al. “Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival..” Int J Cancer, February 8, 2019. https://doi.org/10.1002/ijc.32194.

PMID
30734280
Full Text

Luo, Xiaoning, Erich M. Sturgis, Zheng Yang, Yan Sun, Peng Wei, Zhensheng Liu, Qingyi Wei, and Guojun Li. “Lymphocyte Telomere Length Predicts Clinical Outcomes of HPV-Positive Oropharyngeal Cancer Patients after Definitive Radiotherapy..” Carcinogenesis, February 5, 2019. https://doi.org/10.1093/carcin/bgz019.

PMID
30721961
Full Text

Cheng, Lei, Lixin Qiu, Ruoxin Zhang, Danwen Qian, Mengyun Wang, Menghong Sun, Xiaodong Zhu, Yanong Wang, Weijian Guo, and Qingyi Wei. “Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients..” Int J Cancer 144, no. 2 (January 15, 2019): 251–62. https://doi.org/10.1002/ijc.31656.

PMID
29978580
Full Text

Guo, Y., Y. Feng, H. Liu, and Q. Wei. “Potentially Functional Genetic Variants in the TNF/TNFR Signaling Pathway Genes Predict Survival of Non-Small Cell Lung Cancer Patients in the PLCO Cancer Screening Trial and mRNA Expression Levels in the TCGA.” In American Journal of Respiratory and Critical Care Medicine, Vol. 199. AMER THORACIC SOC, 2019.

Scholars@Duke

Xu, Yinghui, Hongliang Liu, Shun Liu, Yanru Wang, Jichun Xie, Thomas E. Stinchcombe, Li Su, et al. “Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer..” Int J Cancer 143, no. 10 (November 15, 2018): 2400–2408. https://doi.org/10.1002/ijc.31660.

PMID
29978465
Full Text

Guo, Yi, and Qingyi Wei. “GENETIC VARIANTS IN THE C-MYB SIGNALING PATHWAY GENES PREDICT SURVIVAL OF NON-SMALL CELL LUNG CANCER PATIENTS IN THE PLCO CANCER SCREENING TRIAL.” In Respirology, 23:19–20. WILEY, 2018.

Scholars@Duke

Feng, Yun, Yi Guo, Hongliang Liu, and Qingyi Wei. “GENETIC VARIANTS IN THE TNF/TNFR SIGNALING PATHWAY GENES ARE ASSOCIATED WITH SURVIVAL OF NONSMALL-CELL LUNG CANCER PATIENTS.” In Respirology, 23:282–282. WILEY, 2018.

Scholars@Duke

Zhang, Ruoxin, Fei Zhou, Lei Cheng, Alexandria Yu, Meiling Zhu, Mengyun Wang, Zhuanxu Zhang, Jiaqing Xiang, and Qingyi Wei. “Genetic variants in nucleotide excision repair pathway predict survival of esophageal squamous cell cancer patients receiving platinum-based chemotherapy..” Mol Carcinog 57, no. 11 (November 2018): 1553–65. https://doi.org/10.1002/mc.22877.

PMID
30035334
Full Text

Pages